Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease
Author:
Affiliation:
1. Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, United States
2. Novartis Institute for Biomedical Research, Emeryville, California 94608, United States
Funder
Novartis
Publisher
American Chemical Society (ACS)
Subject
Infectious Diseases
Link
https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.3c00125
Reference64 articles.
1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
2. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
3. An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
4. Remdesivir for the Treatment of Covid-19 — Final Report
5. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo;Nature Communications;2024-08-01
2. Phylogenetic signatures reveal multilevel selection and fitness costs in SARS-CoV-2;Wellcome Open Research;2024-07-24
3. Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir;npj Viruses;2024-06-24
4. Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan;Emerging Infectious Diseases;2024-06
5. Subpocket-Based Analysis Approach for the Protein Pocket Dynamics;Journal of Chemical Theory and Computation;2024-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3